India & Coalition for Epidemic Preparedness Innovations

India: India has generously donated emergency pharmaceutical supplies to the United States — Centers for Disease Control and Prevention to aid in the Ebola response in the Democratic Republic of the Congo, demonstrating its commitment to global health security.

Coalition for Epidemic Preparedness Innovations: The Coalition for Epidemic Preparedness Innovations (CEPI) is funding three groups, including Moderna and the University of Oxford, to accelerate the development of vaccines against the Bundibugyo strain of Ebola.

India: India, along with the African Union, postponed the India-Africa Forum Summit due to the evolving health situation in parts of Africa, demonstrating the international repercussions of the Ebola outbreak.

Coalition for Epidemic Preparedness Innovations: The Coalition for Epidemic Preparedness Innovations (CEPI) funds vaccine development and is assessing potential Ebola vaccine candidates, aiming for a rapid response.

India: Home to Serum Institute of India, manufacturing vaccine doses. Its role is in vaccine production.

Coalition for Epidemic Preparedness Innovations: Funding vaccine development efforts, including the Oxford and Hilleman candidates. Its investment is critical for accelerating vaccine research.

India: India is partnering with the United States — Centers for Disease Control and Prevention to deliver medical supplies to aid in the Ebola response.

Coalition for Epidemic Preparedness Innovations: CEPI is listed as a partner in the urgent coordination meeting convened by Africa CDC, indicating potential involvement in the response to the Ebola outbreak.

Coalition for Epidemic Preparedness Innovations: The Coalition for Epidemic Preparedness Innovations tracks emerging disease threats and funds the development of medical tools, including a Nipah vaccine.